These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 28024998)

  • 1. Development and validation of a cell-based fluorescent method for measuring antibody affinity.
    Yu X; Pegram CN; Bigner DD; Chandramohan V
    J Immunol Methods; 2017 Mar; 442():49-53. PubMed ID: 28024998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of novel affinity-matured human chondroitin sulfate proteoglycan 4 antibody fragments by yeast display.
    Yu X; Qu L; Bigner DD; Chandramohan V
    Protein Eng Des Sel; 2017 Sep; 30(9):639-647. PubMed ID: 28981720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput screening of hybridoma supernatants using multiplexed fluorescent cell barcoding on live cells.
    Lu M; Chan BM; Schow PW; Chang WS; King CT
    J Immunol Methods; 2017 Dec; 451():20-27. PubMed ID: 28803843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing properties of antireceptor antibodies using kinetic computational models and experiments.
    Harms BD; Kearns JD; Su SV; Kohli N; Nielsen UB; Schoeberl B
    Methods Enzymol; 2012; 502():67-87. PubMed ID: 22208982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Two-in-One" approach for bioassay selection for dual specificity antibodies.
    Lee HY; Schaefer G; Lesaca I; Lee CV; Wong PY; Jiang G
    J Immunol Methods; 2017 Sep; 448():74-79. PubMed ID: 28579366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Going native: Direct high throughput screening of secreted full-length IgG antibodies against cell membrane proteins.
    Fang Y; Chu TH; Ackerman ME; Griswold KE
    MAbs; 2017; 9(8):1253-1261. PubMed ID: 28933630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Shortcomings of traditional method for determining antibody affinity and their correction].
    Bobrovnik SA; Demchenko MA; Komisarenko SV
    Ukr Biokhim Zh (1999); 2009; 81(3):66-76. PubMed ID: 19877431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding affinity determination of therapeutic antibodies to membrane protein targets: Kinetic Exclusion Assay using cellular membranes for anti-CD20 antibody.
    Vaish A; Lin JS; McBride HJ; Grandsard PJ; Chen Q
    Anal Biochem; 2020 Nov; 609():113974. PubMed ID: 33010205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric cell-based assay to preselect antibody constructs for radionuclide conjugation.
    Ingargiola M; Dittfeld C; Runge R; Zenker M; Heldt JM; Steinbach J; Cordes N; Baumann M; Kotzerke J; Kunz-Schughart LA
    Cytometry A; 2012 Oct; 81(10):865-73. PubMed ID: 22930585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
    Wang X; Campoli M; Ko E; Luo W; Ferrone S
    J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic quantification of antigen molecules with flow cytometry.
    Moskalensky AE; Chernyshev AV; Yurkin MA; Nekrasov VM; Polshchitsin AA; Parks DR; Moore WA; Filatenkov A; Maltsev VP; Orlova DY
    J Immunol Methods; 2015 Dec; 427():139-47. PubMed ID: 27030828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors.
    Liu L; Barth RF; Adams DM; Soloway AH; Reisfeld RA
    J Hematother; 1995 Oct; 4(5):477-83. PubMed ID: 8581388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Measurement of affinity constant of monoclonal antibody by competitive antibody binding to antigen].
    Guo JB; Guo R; Liu YH
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):1057-9. PubMed ID: 16864113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of anti-hECSM2 mouse monoclonal antibodies and their application in the analysis of hECSM2 expression.
    Chen L; Ma C; He J; He Y; Wang J; Gou L; Yang J
    Monoclon Antib Immunodiagn Immunother; 2013 Aug; 32(4):301-8. PubMed ID: 23909426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).
    Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K
    MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of the affinity of high- and low-affinity antibodies, which are in a mixture, using ELISA and the method of non-linear regression].
    Bobrovnik SA
    Ukr Biokhim Zh (1999); 2005; 77(3):155-61. PubMed ID: 16566144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A radioimmunoassay-based method for measuring the true affinity of a monoclonal antibody with trace amounts of radioactive antigen: illustration with the products of a cell-free protein synthesis system.
    Friguet B; Fedorov A; Serganov AA; Navon A; Goldberg ME
    Anal Biochem; 1993 May; 210(2):344-50. PubMed ID: 8512069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: determination of affinities and specificities of monoclonal antibodies by using biotin-labeled antibodies and avidin as precipitating agent in a solution phase immunoassay.
    Wagener C; Clark BR; Rickard KJ; Shively JE
    J Immunol; 1983 May; 130(5):2302-7. PubMed ID: 6187848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological activity in vitro of anti-epidermal growth factor receptor monoclonal antibodies with different affinities.
    Diaz Miqueli A; Blanco R; Garcia B; Badia T; Batista AE; Alonso R; Montero E
    Hybridoma (Larchmt); 2007 Dec; 26(6):423-31. PubMed ID: 18158788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of monoclonal antibody 155.8 and partial characterization of its proteoglycan antigen on human melanoma cells.
    Harper JR; Bumol TF; Reisfeld RA
    J Immunol; 1984 Apr; 132(4):2096-104. PubMed ID: 6199423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.